-
OTC Markets Group On The Importance Of Investor Relations During A Pandemic
Tuesday, March 2, 2021 - 9:09am | 878The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The COVID-19 pandemic brought about unprecedented macroeconomic challenges and greatly impacted the business operations and financial...
-
These Were The Most Active Securities On OTC Markets In October
Wednesday, November 13, 2019 - 10:20am | 1176The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Dollar trading volume on OTC Markets topped $29 billion in October, approximately a 4.5% increase from September. For the month, total...
-
Watchmakers Caught In The #Francogeddon Storm
Friday, January 16, 2015 - 3:39pm | 475With Thursday’s shock that the Swiss National Bank decided to abandon its currency cap still sending shockwaves through the markets, Swiss companies that deal in exports are beginning to fear the worst. Related Link: Swiss ETFs React To Currency News Scrap The Cap Switzerland’s...
-
Wall Street's Wheelings And Dealings
Tuesday, January 13, 2015 - 3:49pm | 571Last year's influx of mergers and acquisitions looks likely to continue, as January kicked off with several big names buying and selling in an effort to better position themselves. Here's a round of up the latest wheelings and dealings generating buzz on Wall Street. Roche Holding Looks...
-
These 2 Dodge & Cox Funds Are Big Hewlett-Packard Owners
Tuesday, December 2, 2014 - 3:44pm | 462When companies report earnings, big institutional owners such as mutual funds look for an opportunity to either add to or pare positions. Post-earnings price movements driven by funds are most evident in smaller or younger stocks, which tend to be more volatile. However, even when a widely...
-
Roche And Biogen Idec (BIIB) Suspend Rheumatoid Arthritis Drug Program
Monday, March 8, 2010 - 9:07am | 119Swiss pharmaceutical company Roche Holding AG and Biogen Idec Inc (Nasdaq: BIIB) announced on Monday that safety concerns had caused them to suspend a program to treat rheumatoid arthritis with drug candidate ocrelizumab. The independent Data and Safety Monitoring Board had found that the potential...